Periodontal Treatment Market to Surpass $12.2 Billion by 2031, Driven by Rising Oral Health Awareness | TMR Analysis

The global periodontal treatment market, valued at US$7.6 billion in 2021, is anticipated to experience steady growth over the next decade. It is projected to grow at a compound annual growth rate (CAGR) of 4.8% from 2022 to 2031, surpassing US$12.2 billion by the end of 2031. This consistent expansion reflects the rising demand for therapies addressing gum diseases, driven by increasing periodontal disease prevalence, aging populations, and advancements in dental care. As oral health gains recognition as a critical component of overall wellness, the market is poised to grow by over 60%, reinforcing its vital role in dental healthcare through 2031.

Get Sample PDF Brochure from here: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85283

Understanding the Periodontal Treatment Market

Periodontal treatment encompasses non-surgical and surgical interventions for gum diseases like gingivitis and periodontitis, which involve inflammation and infection of the gums and supporting bone. Treatments include scaling and root planing (SRP), antibiotic therapy, laser therapy, and surgeries like flap procedures or bone grafts. The 2021 valuation of US$7.6 billion underscores its established importance, with the projected rise to over US$12.2 billion by 2031 highlighting its response to a widespread oral health challenge.

The 4.8% CAGR signals a stable yet dynamic growth phase, balancing traditional therapies with technological advancements. Periodontal disease's link to systemic health drives sustained market momentum.

Key Drivers of Market Growth

Several factors are propelling the periodontal treatment market toward its US$12.2 billion milestone by 2031. First, the high prevalence of periodontal disease is a primary driver. The CDC estimates that 47% of adults over 30 have some form of periodontal disease, rising to 70% in those over 65. Aging populations-projected to exceed 1 billion over 65 by 2030-amplify this burden, aligning with the market's 4.8% CAGR as demand for gum care surges.

Second, advancements in dental technology are accelerating growth. Minimally invasive techniques, like laser-assisted periodontal therapy, reduce recovery time and improve outcomes compared to traditional surgery. Adjuncts such as locally delivered antibiotics (e.g., Arestin) and regenerative materials for bone loss enhance treatment efficacy, driving the market toward US$12.2 billion by expanding clinical options.

Third, rising oral health awareness and dental care access are boosting the market. Public health campaigns, like the FDI World Dental Federation's advocacy for gum health, encourage regular checkups, while insurance coverage for periodontal procedures grows. Expanding dental clinics in emerging economies, supported by initiatives like India's National Oral Health Programme, reinforces the market's trajectory through 2031.

Leading Players:

Amyndas Pharmaceuticals
3M
AMD Lasers, Inc.
ASA Dental S.p.A,
Biolase, Inc.
Carl Martin GmbH
Danaher
Dentsply Sirona
Deppeler SA
Karl Schumacher
Medtronic
Novartis AG
Pfizer, Inc.
Planmeca Oy
Steris-Hu-Friedy
Straumann AG

Visit our report to discover essential insights and analysis - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85283

Market Segmentation and Regional Insights

The market segments by treatment type, end-user, and geography. Non-surgical treatments, like SRP and antibiotics, dominate due to their first-line use, followed by surgical options for advanced cases. End-users include dental clinics, hospitals, and ambulatory centers, with clinics leading due to accessibility. Distribution occurs via direct sales, dental suppliers, and online platforms for adjunctive products.

Regionally, North America held a significant share of the US$7.6 billion valuation in 2021, driven by high disease prevalence, advanced dental infrastructure, and strong reimbursement in the United States. Europe followed, with robust markets in Germany and the UK, supported by aging demographics and universal healthcare. The Asia-Pacific region, however, is expected to see the fastest growth through 2031, fueled by rising diabetes (a periodontitis risk factor), dental tourism, and clinic expansion in China and India.

Challenges and Opportunities

The market faces challenges. Limited awareness in developing regions delays diagnosis, while high costs of advanced treatments, like laser therapy (thousands per session), restrict access. Reimbursement gaps for surgical procedures and competition from general dentistry also hinder growth. The 4.8% CAGR reflects a market navigating these constraints with steady progress.

These challenges, however, present opportunities. Companies developing affordable laser devices or over-the-counter periodontal aids could broaden access, supporting the push to US$12.2 billion. Innovations in teledentistry for early screening or biomaterials for regeneration offer growth potential, while oral health campaigns in emerging markets could exceed projections. Partnerships with insurers to cover advanced therapies could further enhance uptake.

The Road to 2031

By 2031, the global periodontal treatment market is projected to surpass US$12.2 billion, reflecting ten years of steady growth at a 4.8% CAGR from US$7.6 billion in 2021. This milestone is driven by disease prevalence, technological advancements, and oral health priorities. As the forecast concludes, the market's trajectory suggests continued expansion, with potential for preventive periodontal solutions to shape future dental care.

In conclusion, the periodontal treatment market demonstrates solid growth from 2022 to 2031. Rising from US$7.6 billion to over US$12.2 billion, it addresses a critical oral health challenge with impactful solutions. Stakeholders-from dental professionals to device makers-play a vital role in this success, ensuring effective, accessible treatments improve patient outcomes worldwide through 2031 and beyond.

Explore Latest Research Reports by Transparency Market Research:

Pharma 4.0 Market: https://www.pharmiweb.com/press-release/2025-03-18/pharma-40-market-size-will-estimated-to-grow-at-a-cagr-of-177-by-2035-driven-by-digital-transformation-in-drug-manufacturing-exclusive-report-by

Dialysis Equipment Market: https://www.pharmiweb.com/press-release/2025-03-18/dialysis-equipment-market-poised-to-surpass-us-252-bn-by-2035-amidst-rising-ckd-cases-and-technological-advancements-tmr-insights

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact Us:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com

This release was published on openPR.